---
title: Asimov vs WuXi Vaccines
slug_a: asimov
slug_b: wuxivaccines
site: cdmo
review_signal_gate: closed
canonical_path: /compare/asimov/wuxivaccines
---

# Asimov vs WuXi Vaccines

Side-by-side profile data from each company listing on this directory.

## Asimov

- Profile: [/companies/asimov](/companies/asimov)

Asimov — Asimov provides cell line development, upstream process development, and viral vector manufacturing services powered by proprietary synthetic biology platforms (CHO Edge, LV Edge, AAV Edge, RNA Edge) that deliver high-titer, stable cell lines and production systems for biologics, cell therapies, and gene therapies.

Services: 11. Modalities: 5. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Cell-Free
- Single-Use / Disposable

## WuXi Vaccines

- Profile: [/companies/wuxivaccines](/companies/wuxivaccines)

WuXi Vaccines — Global CDMO specializing in end-to-end vaccine and prophylactic antibody development and manufacturing across mammalian, viral, and microbial platforms with GMP-certified facilities and over 550 million doses delivered.

Services: 11. Modalities: 4. Indications: 1. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vaccine Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- mRNA
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector